JORNAY PM is an extended-release methylphenidate capsule taken in the evening to provide symptom control from morning through early evening. Its dosing profile aims to simplify routines and support daily activities, addressing common challenges like morning sluggishness and afternoon symptom lapses. Collegium Pharmaceutical unveiled the 'Embrace Your Sparkle' campaign in partnership with Paris Hilton to reframe perceptions of ADHD and encourage open dialogue. The campaign leverages Hilton's personal experience to destigmatize the condition and highlight the importance of individualized treatment plans. ADHD affects approximately 15.5 million adults and 6.5 million children in the United States, with 70% of childhood cases persisting into adulthood. Underrecognition in adults contributes to delayed diagnosis, presenting a significant opportunity for targeted awareness initiatives and expanded treatment uptake. By raising visibility through a high-profile celebrity campaign, Collegium aims to drive prescription volumes and capture greater market share in the ADHD treatment segment. Increased adoption of JORNAY PM could enhance the company's revenue growth and strengthen its competitive position.